Go to the list of all blogs
Alicia's Avatar
published in Blogs
Apr 03, 2026
Shell plc (SHEL): +13% in 30 Days and +25% in the Quarter Amid Oil Surge and Buybacks

Shell plc (SHEL): +13% in 30 Days and +25% in the Quarter Amid Oil Surge and Buybacks

Key Takeaways

  • SHEL stock rose +13% over the last 30 days, driven by surging oil prices amid Middle East geopolitical tensions and ongoing share buybacks.
  • Over the past quarter, the stock gained +25%, reflecting strong energy sector momentum and resilient LNG operations.
  • Key factors include elevated crude prices from Iran-related disruptions, analyst upgrades, and Shell's consistent shareholder returns via dividends and repurchases.
  • Macro influences like supply concerns in the Strait of Hormuz boosted sentiment, outweighing any operational hiccups.
  • Buyback programs and potential new gas deals in Venezuela supported price stability and upside.

Understanding Shell plc (SHEL) and Its Market Position

Shell plc (SHEL) stands as a British multinational energy company deeply involved in oil and gas exploration, production, refining, and marketing. Its business spans integrated gas (including LNG), upstream production, downstream refining and chemicals, and renewables. As one of the supermajors, Shell maintains a strong competitive edge in the global energy sector, bolstered by peer-leading LNG resources and deepwater assets. From what I see, this diversified setup—high-margin LNG paired with stable liquids production—has been key to the stock's recent resilience, as higher commodity prices lift upstream cash flows and trading operations thrive on volatility.

SHEL Stock Performance: The Last 30 Days and Quarter in Review

In the last 30 days, SHEL stock climbed +13%, moving from around $82.33 to close at $93.10. The advance showed a clear trend with moderate volatility, reaching a peak near $94.90 before consolidating alongside broader market gains in energy. One thing that stands out is how this steady rise tracked the sector's overall strength.

Looking at the past quarter, shares jumped +25% from about $74.74, driven by persistent positive catalysts. The performance stayed range-bound at points but pushed higher on commodity rallies, outpacing benchmarks like the FTSE 100.

Key Drivers Behind SHEL's +13% Gain in the Last 30 Days

The +13% increase largely came from soaring oil prices, with Brent up over 60% in March due to Middle East tensions, such as Iran strikes on facilities like Qatar's Pearl GTL plant—where Shell has a stake. These events tightened supply, pushing crude toward $140/barrel and raising expectations for upstream earnings.

Shell's March 31 buyback update, affirming continued repurchases, added to shareholder confidence during the rally. I also checked analyst upgrades from JPMorgan, Berenberg, and TD Cowen, which lifted price targets based on LNG growth and oil tailwinds. Geopolitical risks near the Strait of Hormuz further lifted sector sentiment, with Shell's integrated model well-positioned to benefit from the volatility.

What Powered SHEL's +25% Quarterly Performance

The +25% quarterly gain built on recovering energy demand and solid commodity prices following Q4 2025 earnings. Even with softer Q4 profits from lower oil prices, Shell's $3.5 billion buyback—its 17th straight quarter above $3 billion—and 4% dividend increase kept distributions steady, attracting institutional buyers.

Escalating Iran tensions drove oil higher, playing to the strengths of Shell's upstream and LNG assets. Developments like talks for Venezuelan gas fields pointed to future growth. In my view, investors have gravitated toward majors like SHEL with low breakeven prices around $40/bbl, offering resilience in an environment of inflation and rate pressures.

Discovering an Edge with Tickeron's Trending AI Robots

In my own research process, I often turn to Tickeron’s Trending AI Robots to spot high-performing automated strategies. This page highlights the platform's top AI trading bots from hundreds available, which scan and trade thousands of tickers using various approaches, timeframes, and metrics. It curates bots showing strong recent performance—like those using pattern recognition for short-term swings or trend-following for longer-term positions—which can be particularly useful in volatile sectors such as energy. With transparent backtested and live results, whether for momentum, mean reversion, or volatility trades, it's a practical way to enhance analysis on stocks like SHEL. I find it helps sharpen my edge in identifying opportunities.

What to Watch Next for SHEL Stock Forecasts

I'm watching upcoming Q1 2026 earnings closely for updates on upstream volumes and LNG trading, especially with oil prices elevated. Key trends include global LNG demand growth and offshore expansions, such as potential Venezuelan deals. Macro factors like interest rates, inflation, and Middle East supply risks could influence sentiment. Strategic decisions on buybacks, divestments, and capital toward high-return areas like deepwater deserve attention. On the risk side, watch for operational disruptions, price corrections, or shifts in energy transition regulations.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: SHEL

Contributor

Alicia's AvatarAlicia|Beginner

SHEL in +0.95% Uptrend, rising for three consecutive days on October 05, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SHEL advanced for three days, in 192 of 365 cases, the price rose further within the following month. The odds of a continued upward trend are 53%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on SHEL as a result. In 51 of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 52%.

The Aroon Indicator entered an Uptrend today. In 163 of 333 cases where SHEL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 49%.

Bearish Trend Analysis

The 10-day RSI Indicator for SHEL moved out of overbought territory on September 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 16 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 50%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for SHEL turned negative on September 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 20 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 44%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SHEL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 45%.

SHEL broke above its upper Bollinger Band on September 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 5 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 28, placing this stock better than average.

The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.522) is normal, around the industry mean (1.887). P/E Ratio (10.671) is within average values for comparable stocks, (16.521). Projected Growth (PEG Ratio) (1.632) is also within normal values, averaging (1.088). Dividend Yield (0.031) settles around the average of (0.035) among similar stocks. P/S Ratio (0.929) is also within normal values, averaging (3.764).

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. SHEL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are ExxonMobil Holdings Corporation (NYSE:XOM), Chevron Corp (NYSE:CVX), Petroleo Brasileiro Sa-Petrobras ADS (REP 1 Common Share) (NYSE:PBR), BP plc (NYSE:BP), Suncor Energy (NYSE:SU), YPF Sociedad Anonima (NYSE:YPF).

Industry description

Integrated oil companies are involved across nearly the entire oil value chain – from upstream operations like exploration and production, to downstream functions of refining and marketing. Exxon Mobil Corporation, Chevron Corporation and BP are major integrated oil companies. Their bottom lines’ response to crude oil prices could depend on the proportion of upstream vs. downstream businesses; for example, if a company has substantial downstream business, the adverse impact on their upstream business due to falling crude prices could be mitigated by benefits to its downstream business.

Market Cap

The average market capitalization across the Integrated Oil Industry is 124.33B. The market cap for tickers in the group ranges from 63.2K to 668.27B. XOM holds the highest valuation in this group at 668.27B. The lowest valued company is CRRDF at 63.2K.

High and low price notable news

The average weekly price growth across all stocks in the Integrated Oil Industry was 3%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was 5%. PBR experienced the highest price growth at 17%, while TTE experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Integrated Oil Industry was 61%. For the same stocks of the Industry, the average monthly volume growth was 65% and the average quarterly volume growth was -26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 40
P/E Growth Rating: 50
Price Growth Rating: 47
SMR Rating: 55
Profit Risk Rating: 27
Seasonality Score: 14 (-100 ... +100)
View a ticker or compare two or three
SHEL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry IntegratedOil

Industry
N/A
Address
Shell Centre
Phone
+44 2079341234
Employees
85000
Web
https://www.shell.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.
Shell plc (SHEL): +13% in 30 Days and +25% in the Quarter Amid Oil Surge and Buybacks